A detailed history of Retirement Guys Formula LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Retirement Guys Formula LLC holds 1,342 shares of REGN stock, worth $957,181. This represents 0.51% of its overall portfolio holdings.

Number of Shares
1,342
Previous 1,278 5.01%
Holding current value
$957,181
Previous $1.34 Million 28.89%
% of portfolio
0.51%
Previous 0.64%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025

BUY
$701.85 - $1046.91 $44,918 - $67,002
64 Added 5.01%
1,342 $955,000
Q3 2024

Oct 21, 2024

BUY
$1024.09 - $1201.76 $96,264 - $112,965
94 Added 7.94%
1,278 $1.34 Million
Q2 2024

Aug 01, 2024

SELL
$883.2 - $1071.19 $7,948 - $9,640
-9 Reduced 0.75%
1,184 $1.24 Million
Q1 2024

Apr 19, 2024

BUY
$902.69 - $993.35 $1.08 Million - $1.19 Million
1,193 New
1,193 $1.15 Million
Q1 2022

Jul 18, 2022

SELL
$595.12 - $698.43 $274,350 - $321,976
-461 Closed
0 $0
Q4 2021

Jul 18, 2022

BUY
$543.48 - $670.97 $250,544 - $309,317
461 New
461 $291,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.5B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Retirement Guys Formula LLC Portfolio

Follow Retirement Guys Formula LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Guys Formula LLC, based on Form 13F filings with the SEC.

News

Stay updated on Retirement Guys Formula LLC with notifications on news.